Matches in Wikidata for { <http://www.wikidata.org/entity/Q37692345> ?p ?o ?g. }
- Q37692345 description "2017 թվականի մարտի 10-ին հրատարակված գիտական հոդված" @default.
- Q37692345 description "article científic" @default.
- Q37692345 description "article scientifique" @default.
- Q37692345 description "articolo scientifico" @default.
- Q37692345 description "artigo científico" @default.
- Q37692345 description "artículu científicu espublizáu en 2017" @default.
- Q37692345 description "bilimsel makale" @default.
- Q37692345 description "scientific article published on 10 March 2017" @default.
- Q37692345 description "vedecký článok" @default.
- Q37692345 description "vetenskaplig artikel" @default.
- Q37692345 description "videnskabelig artikel" @default.
- Q37692345 description "vědecký článek" @default.
- Q37692345 description "wetenschappelijk artikel" @default.
- Q37692345 description "wissenschaftlicher Artikel" @default.
- Q37692345 description "наукова стаття, опублікована в березні 2017" @default.
- Q37692345 description "научни чланак" @default.
- Q37692345 description "مقالة علمية نشرت في 10 مارس 2017" @default.
- Q37692345 name "Treating triple negative breast cancer cells with erlotinib plus a select antioxidant overcomes drug resistance by targeting cancer cell heterogeneity." @default.
- Q37692345 name "Treating triple negative breast cancer cells with erlotinib plus a select antioxidant overcomes drug resistance by targeting cancer cell heterogeneity." @default.
- Q37692345 name "Treating triple negative breast cancer cells with erlotinib plus a select antioxidant overcomes drug resistance by targeting cancer cell heterogeneity." @default.
- Q37692345 type Item @default.
- Q37692345 label "Treating triple negative breast cancer cells with erlotinib plus a select antioxidant overcomes drug resistance by targeting cancer cell heterogeneity." @default.
- Q37692345 label "Treating triple negative breast cancer cells with erlotinib plus a select antioxidant overcomes drug resistance by targeting cancer cell heterogeneity." @default.
- Q37692345 label "Treating triple negative breast cancer cells with erlotinib plus a select antioxidant overcomes drug resistance by targeting cancer cell heterogeneity." @default.
- Q37692345 prefLabel "Treating triple negative breast cancer cells with erlotinib plus a select antioxidant overcomes drug resistance by targeting cancer cell heterogeneity." @default.
- Q37692345 prefLabel "Treating triple negative breast cancer cells with erlotinib plus a select antioxidant overcomes drug resistance by targeting cancer cell heterogeneity." @default.
- Q37692345 prefLabel "Treating triple negative breast cancer cells with erlotinib plus a select antioxidant overcomes drug resistance by targeting cancer cell heterogeneity." @default.
- Q37692345 P1433 Q37692345-2B58A68A-F836-4806-A226-970AC396C10B @default.
- Q37692345 P1476 Q37692345-77552E88-BA08-441A-B693-7724D2E24D65 @default.
- Q37692345 P2093 Q37692345-0D43963C-C963-4BC5-871F-BADC7D610EA5 @default.
- Q37692345 P2093 Q37692345-2BF9314A-BFDC-4F63-8D69-068C56C65177 @default.
- Q37692345 P2093 Q37692345-42428FC7-DC55-4327-85D8-55B6379E14F7 @default.
- Q37692345 P2093 Q37692345-553798C5-61D3-445A-874D-27F852082AEB @default.
- Q37692345 P2093 Q37692345-576DAC8F-BD7A-4C5F-BC1E-0D9FD95332E8 @default.
- Q37692345 P2093 Q37692345-71A58849-8EC1-4054-96A0-3C8370924E83 @default.
- Q37692345 P2093 Q37692345-C93424E8-0EC1-4CA0-BC86-1C6AC7572354 @default.
- Q37692345 P2093 Q37692345-C93A1F8C-F38E-4190-ACCB-0AE7D57344DE @default.
- Q37692345 P2093 Q37692345-F6C19947-B396-43E9-ADF1-FA81F48DAB3E @default.
- Q37692345 P275 Q37692345-7f7cde53-71a7-47a1-a50d-ece7708012b3 @default.
- Q37692345 P2860 Q37692345-0A6C291B-2AC6-44A4-A867-AC3F80BDF087 @default.
- Q37692345 P2860 Q37692345-1392DB75-CF78-4FAD-B41D-9E50A44AE479 @default.
- Q37692345 P2860 Q37692345-166B23EA-CD53-4B85-99D0-56DA577C97EF @default.
- Q37692345 P2860 Q37692345-16BE3E5A-5E92-444E-A885-C6D8571C820A @default.
- Q37692345 P2860 Q37692345-198CA8AB-A691-47C6-AF29-551774015BA1 @default.
- Q37692345 P2860 Q37692345-1DE0C58C-797C-4631-AD54-25A961DB3475 @default.
- Q37692345 P2860 Q37692345-28722259-9EC0-4039-A0F2-F16A703EA996 @default.
- Q37692345 P2860 Q37692345-3354491B-E7AF-4C84-B257-57833EAC266E @default.
- Q37692345 P2860 Q37692345-3C138EED-3DEB-4EC6-9209-BE108BFE0287 @default.
- Q37692345 P2860 Q37692345-4805CF86-A6E2-4388-B6B8-9B49DDB903BA @default.
- Q37692345 P2860 Q37692345-4C98B86C-D234-488E-844F-EAEEF2BB34B7 @default.
- Q37692345 P2860 Q37692345-52DF9262-BAAB-4701-B8DB-BD565B2DE72B @default.
- Q37692345 P2860 Q37692345-59E16D88-B838-49BE-A27A-A2082F5DA42B @default.
- Q37692345 P2860 Q37692345-5B642FD0-906F-416A-87C8-074E18636546 @default.
- Q37692345 P2860 Q37692345-5C1B4553-3488-48C3-9BB0-664330FE90CA @default.
- Q37692345 P2860 Q37692345-623FF5AB-5D25-4505-8CA6-9AAF2963A0BE @default.
- Q37692345 P2860 Q37692345-6CE884C4-7FD5-4017-97AC-9A7305B374FA @default.
- Q37692345 P2860 Q37692345-78068001-9591-4240-9545-EE3CB6756F06 @default.
- Q37692345 P2860 Q37692345-8693D6CB-F77E-4CD2-9384-46A9D2192B4C @default.
- Q37692345 P2860 Q37692345-8E2869CB-721F-40F0-98D1-AB1DA63027DB @default.
- Q37692345 P2860 Q37692345-957A24AD-C68F-47C5-B7B1-F51DA32B3E68 @default.
- Q37692345 P2860 Q37692345-9DA3175A-2EE2-467A-9D85-0BFACAFDD9D4 @default.
- Q37692345 P2860 Q37692345-A7FE79FA-EEF5-4008-97B4-C698A045ED03 @default.
- Q37692345 P2860 Q37692345-A81DE575-57EA-4BAD-8BD9-C2DA696E72DE @default.
- Q37692345 P2860 Q37692345-A93779EE-F903-496D-AD3C-E25C9FE0DF0A @default.
- Q37692345 P2860 Q37692345-B2E21D4F-0B0B-4472-9BAE-942DB58AC3C9 @default.
- Q37692345 P2860 Q37692345-BEBB47F5-06AF-4E1C-95F4-9A52EC6199A1 @default.
- Q37692345 P2860 Q37692345-D1371183-AD6C-4D10-814D-EAF048056F57 @default.
- Q37692345 P2860 Q37692345-D4711BC9-8687-4FF1-8433-1637B30B8925 @default.
- Q37692345 P2860 Q37692345-DC992901-BBEA-46C2-A6FF-B1AE93F7FAE4 @default.
- Q37692345 P2860 Q37692345-E81EF20E-AB36-4B13-A730-AD6E156F8C37 @default.
- Q37692345 P2888 Q37692345-F6260F70-9A67-449D-8F5F-F13B1A7D0829 @default.
- Q37692345 P304 Q37692345-8E3AC80C-5115-42F7-B92E-A053B93A0FFD @default.
- Q37692345 P31 Q37692345-807FC8EA-3D8E-4C24-87B6-224A57E59C31 @default.
- Q37692345 P356 Q37692345-1090E305-C58D-4B44-AE84-14B41376E69D @default.
- Q37692345 P407 Q37692345-1216A3F9-136F-43D5-B249-77AA746BE7BB @default.
- Q37692345 P478 Q37692345-395C2BC2-1D73-424C-B20A-C3DABDFDAB39 @default.
- Q37692345 P50 Q37692345-294DD789-7059-445F-AB0F-C96CF88740B7 @default.
- Q37692345 P50 Q37692345-499FF8ED-A7B6-479D-86F9-0986D433CCBE @default.
- Q37692345 P577 Q37692345-1A8C173A-EB8D-4353-BA8D-B276674758B5 @default.
- Q37692345 P6216 Q37692345-dae9234e-9ef1-42f3-95f4-680ef167cc4a @default.
- Q37692345 P698 Q37692345-782A8979-CAB0-4E91-83DD-95CBAFBB9212 @default.
- Q37692345 P921 Q37692345-7FAE398A-8442-46AE-A30F-923360337C81 @default.
- Q37692345 P932 Q37692345-40D7860E-CBAF-4A5F-8DFE-F2CA494D5B07 @default.
- Q37692345 P356 SREP44125 @default.
- Q37692345 P698 28281569 @default.
- Q37692345 P1433 Q2261792 @default.
- Q37692345 P1476 "Treating triple negative breast cancer cells with erlotinib plus a select antioxidant overcomes drug resistance by targeting cancer cell heterogeneity" @default.
- Q37692345 P2093 "Bin Bao" @default.
- Q37692345 P2093 "Cristina Mitrea" @default.
- Q37692345 P2093 "Emily Girsch" @default.
- Q37692345 P2093 "Greg Dyson" @default.
- Q37692345 P2093 "Julie L Boerner" @default.
- Q37692345 P2093 "Priyanga Wijesinghe" @default.
- Q37692345 P2093 "Ramzi Mohammad" @default.
- Q37692345 P2093 "Rebecca L Farr" @default.
- Q37692345 P2093 "Stanley R Terlecky" @default.
- Q37692345 P275 Q20007257 @default.
- Q37692345 P2860 Q26787065 @default.
- Q37692345 P2860 Q26850892 @default.
- Q37692345 P2860 Q27667510 @default.